A groundbreaking shift in our drug policy has happened, as the regulators announce the availability of psilocybin fungi for therapeutic purposes. Before this, these substances were strictly restricted, but a growing body of studies suggests they potentially offer benefits for psychological conditions like anxiety. The new policy represents a major